The Use of Dehydrated Human Amniotic Membrane Versus Amniotic/Chorionic Membrane Allografts to Treat Partial Thickness Facial Burns

The Journal of Craniofacial Surgery
Salomon PuyanaHaaris Mir

Abstract

Facial burns have significant physical and psychologic effects on patients. Human dehydrated amniotic membrane represents novel technology, yet its outcome has not been sufficiently studied to guide practice. The objective of our study is to compare the benefits of amniotic membrane (DHAM) to amniotic/chorionic membrane (DHACM) skin substitutes to treat partial thickness facial burns. Retrospective review of data collected from our institutional burn registry from 2012 to 2016. Demographic characteristics including age, total body surface area (TBSA) burn and injury severity scores were collected and outcome measures were compared between the 2 groups. Paired sample t-test and Chi-squared were used with significance defined as P < 0.05. A total of 77 adult patients with partial thickness facial burns who received DHAM and DHACM skin substitutes were included in the analysis. The mean age for the DHAM group was 39.8 compared to 41.4 for the DHACM. Mean TBSA was similar, with 10.9% in the DHAM group compared to 8.3% in the DHACM. Patients receiving DHAM had higher requirement for skin substitute surgical reapplications as compared to the DHACM group (23.7% versus 5.1%, P ≤ 0.05). Remaining morbidities remained low and not signifi...Continue Reading

References

Jun 1, 1982·Annals of Plastic Surgery·J O KucanR W Parsons
May 9, 2006·Journal of Burn Care & Research : Official Publication of the American Burn Association·Hans-Oliver RennekampffHans-Eberhard Schaller
Jan 26, 2007·Journal of the Royal Society, Interface·Anthony D Metcalfe, Mark W J Ferguson
Oct 9, 2007·Burns : Journal of the International Society for Burn Injuries·Ludwik K BranskiMarc G Jeschke
Jul 25, 2008·The Journal of Craniofacial Surgery·Theodore A Kung, Arun K Gosain
Apr 18, 2013·Burns : Journal of the International Society for Burn Injuries·Cornelis J HoogewerfMarianne K Nieuwenhuis
Mar 26, 2014·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Thomas J KoobGuilhem Denozière
Jun 15, 2014·Burns : Journal of the International Society for Burn Injuries·M J HopE Middelkoop
Sep 2, 2014·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Thomas J KoobMichelle Massee
Jan 31, 2015·Cell and Tissue Banking·Anahí Sanluis-VerdesMaria Esther Rendal-Vázquez
Jun 15, 2018·Journal of Burn Care & Research : Official Publication of the American Burn Association·Colleen M RyanUNKNOWN Multi-Center Benchmarking Study Group

❮ Previous
Next ❯

Citations

Dec 24, 2020·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Sarah GulameabasseMathilde Fenelon
Sep 1, 2021·Journal of the Korean Association of Oral and Maxillofacial Surgeons·Monica GajulSonal Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.